4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Oprozomib [ONX 0912]/AG-CR1-3672-M025/25 mg
商品详细Adipogen/Oprozomib [ONX 0912]/AG-CR1-3672-M025/25 mg
Adipogen/Oprozomib [ONX 0912]/AG-CR1-3672-M025/25 mg
Adipogen/Oprozomib [ONX 0912]/AG-CR1-3672-M025/25 mg
商品编号: AG-CR1-3672-M025
品牌: Adipogen Inc
市场价: ¥6600.00
美元价: 3960.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsO-Methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-L-serinamide;PR-047
ProductTypeChemical
Properties
FormulaC25H32N4O7S
MW532.6
CAS935888-69-0
PurityChemicals≥98%
AppearanceWhitesolid.
SolubilitySolubleinDMSO(20mg/ml)orDMF(10mg/ml).Sparinglysolubleinethanol(1mg/ml).Poorlysolubleinaqueousbuffers.
OtherProductDataNote:Warmingandsonicationmayberequiredwhendissolvingthecompoundinthesolventofchoice.Stocksolutionsarestableforatleast1monthwhenstoredat-20°C.
InChiKeySWZXEVABPLUDIO-WSZYKNRRSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • PotentorallybioavailableirreversIBLeproteasomeinhibitor.AnalogofCarfilzomib(Prod.No.AG-CR1-3669).
  • Targetsthechymotrypsin-likeβ5subunitoftheconstitutive20Sproteasome(IC50=36nM)andtheβ5isubunit[LMP7]ofthe20Simmunoproteasome(IC50=82nM).
  • Anticancercompoundeffectiveincell-basedassays,inxenograftsandagainstmultiplemyelomainvivo.
  • Invitro,inducescellcyclearrestandapoptosisinhumancancercelllinesincludingmultiplemyeloma,aswellasinbortezomibresistantmultiplemyelomacells.
  • Showntohaveanti-angiogenicactivity.
  • Haspotentialapplicationsincertaintypesofcanceraswellasotherdiseasesthatrequireproteasomeactivity.
ProductReferences
  1. Designandsynthesisofanorallybioavailableandselectivepeptideepoxyketoneproteasomeinhibitor(PR-047):H.J.Zhou,etal.;J.Med.Chem.52,3028(2009)
  2. AnovelorallyactiveproteasomeinhibitorONX0912triggersinvitroandinvivocytotoxicityinmultiplemyeloma:D.Chauhan,etal.;Blood116,4906(2010)
  3. Theepoxyketone-basedproteasomeinhibitorscarfilzomibandorallybioavailableoprozomibhaveanti-resorptiveandbone-anabolicactivityinadditiontoanti-myelomaeffects:M.A.Hurchla,etal.;Leukemia27,430(2013)
  4. CarfilzomibandONX0912inhibitcellsurvivalandtumorgrowthofheadandneckcancerandtheiractivitiesareenhancedbysuppressionofMcl-1orautophagy:Y.Zang,etal.;Clin.CancerRes.18,5639(2012)
  5. ThenextgenerationproteasomeinhibitorscarfilzomibandoprozomibactivateprosurvivalautophagyviainductionoftheunfoldedproteinresponseandATF4:Y.Zang,etal.;Autophagy8,1873(2012)
  6. Effectofnovelproteasomeandimmunoproteasomeinhibitorsondendriticcellmaturation,function,andexpressionofIκBandNFκB:A.S.Al-Homsi,etal.;Transpl.Immunol.29,1(2013)
  7. Overviewofproteasomeinhibitor-basedanti-cancertherapies:Perspectiveonbortezomibandsecondgenerationproteasomeinhibitorsversusfuturegenerationinhibitorsofubiquitin-proteasomesystem:Q.P.Dou&J.A.Zonder;Curr.CancerDrugTargets14,517(2014)
  8. Proteasomeinhibitors-molecularbasisandcurrentperspectivesinmultiplemyeloma:L.Kubiczkova,etal.;J.Cell.Mol.Med.18,947(2014)
  9. Next-generationproteasomeinhibitoroprozomibsynergizeswithmodulatorsoftheunfoldedproteinresponsetosuppresshepatocellularcarcinoma:Y.P.Vandewynckel,etal.;Oncotarget7,34988(2016)
  10. SecondGenerationProteasomeInhibitorsinMultipleMyeloma:A.Gozzetti,etal.;AnticancerAgentsMed.Chem.17,920(2017)
  11. Anti-angiogenicandanti-multiplemyelomaeffectsofoprozomib(OPZ)aloneandincombinationwithpomalidomide(Pom)and/ordexamethasone(Dex):E.Sanchez,etal.;Leuk.Res.57,45(2017)(Review)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。